In breast and lung cancer cells CD44 was shown to be a key regulator of PD-L1 expression following shRNA-directed knockdown of CD44 in vitro and in vivo using a metastatic breast cancer xenograft mouse model (180). The gene discussed is CD44; the disease is lung carcinoma.